Evidence map›Paper›PMID 41898442›Full record

ArticleInternational journal of molecular sciences2026

Early Reduction in Mitochondrial Membrane Potential in Synaptic Mitochondria Contribute to Synaptic Pathology in the EAE Mouse Model of Multiple Sclerosis.

Dalia R Ibrahim, Karin Schwarz, Ajay Kesharwani, René Tinschert, Shweta Suiwal, Frank Schmitz

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dalia R IbrahimDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany.ORCID 0009-0002-2554-1244
Karin SchwarzDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany.ORCID 0000-0002-7328-1427
Ajay KesharwaniDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany.ORCID 0000-0001-6001-842X
René TinschertDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany.
Shweta SuiwalDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany.
Frank SchmitzDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Saarland University, 66421 Homburg, Germany.ORCID 0000-0003-1457-6222

Funding

Dr. Rolf M. Schwiete Foundation 2021-022
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a highly disabling chronic autoimmune disease of the central nervous system with neuroinflammatory and neurodegenerative alterations found in the white and grey matter of the brain. The pathogenesis of MS is complex and not fully understood. Mitochondrial dysfunctions are suspected to play an important role. The visual system is often affected in MS. Optic neuritis is a frequent symptom, but also the retina itself, including retinal synapses appear compromised in MS independent from demyelination of the optic nerve. A previous study demonstrated synapse-specific alterations of mitochondria in photoreceptor synapses in the Experimental Autoimmune Encephalomyelitis (EAE) mouse model of MS at day 9 after injection, an early time point in pre-clinical EAE. In the present study, we analysed even earlier stages of pre-clinical EAE for possible alterations of synaptic mitochondria. For this purpose, we performed qualitative and quantitative immunolabelling analyses of the mitochondrial cristae organising protein MIC60 at retinal synapses and functional analyses by measuring synaptic mitochondrial membrane potential (during rest and depolarisation-induced exocytosis) and visually guided behaviour (optometry analyses). At day 3 after injection, morphological and functional data were indistinguishable between MOG/CFA-injected EAE mice and CFA-injected control mice. But already on day 5 after injection, we observed a decreased expression of the mitochondrial MIC60 protein at synaptic mitochondria, a decreased synaptic mitochondrial membrane potential at rest, an enhanced drop of mitochondrial membrane potential during stimulated exocytosis and a decreased visual performance of the respective EAE mice. These data argue that synaptic pathology in the EAE retina begins as early as day 5 after injection. Our data propose that dysfunctions of mitochondria play an important role already at the very early stages of synaptic pathology in EAE.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMembrane Potential, MitochondrialMitochondriaMultiple SclerosisSynapsesAnimalsDisease Models, AnimalFemaleMiceMice, Inbred C57BLRetinaEAEMIC60mitochondriamitochondrial membrane potentialmultiple sclerosisretinaribbon synapse

Identifiers

PMID41898442
PMCPMC13027089

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.